Pain Relief by Parecoxib for Laparoscopic Cholecystectomy: A Meta-Analysis of Randomized Controlled Trials

Yu Cih Lin, Chien Yu Chen, Yuan Mei Liao, Pi Chu Lin, Chuen Chau Chang

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: The aim of this meta-analysis is to verify the effectiveness of postoperative pain relief by perioperative parecoxib, a selective intravenous cyclooxygenase-2 (COX-2) inhibitor, for patients receiving laparoscopic cholecystectomy (LC) surgery. METHODS: Electronic databases were searched for the randomized controlled trials (RCTs) to evaluate the effectiveness of pain relief by parecoxib or placebo for patients receiving LC surgery. The primary outcomes was the pain score evaluation using visual analogue scale (VAS). The secondary outcomes were the opioids consumption or analgesic supplement requirement and incidence of any adverse events such as dizziness, nausea and vomiting. RESULTS: Ten trials with 916 patients were included. Perioperative parecoxib significantly reduced postoperative pain score with rest at post-anaesthesia care unit (PACU; mean difference [MD] = -0.58, 95% confi dence interval [CI] = -1.04 to -0.12, p = 0.01) after LC. Postoperative opioid requirement or analgesic supplement for rescue of pain was also effectively reduced (relative risk [RR] = 0.47, 95% CI = 0.33 to 0.66, p < 0.0001). The incidence of side effects such as postoperative nausea and vomiting (PONV) was unaffected (RR = 0.83, 95% CI = 0.63 to 1.10, p = 0.20). CONCLUSION: Perioperative intravenous parecoxib could effectively provide pain relief and reduced postoperative morphine consumption or rescue analgesics for LC surgery without causing additional adverse concerns.

Original languageEnglish
Pages (from-to)92-114
Number of pages23
JournalAsian Journal of Anesthesiology
Volume56
Issue number3
DOIs
Publication statusPublished - Sep 1 2018

Fingerprint

Laparoscopic Cholecystectomy
Meta-Analysis
Randomized Controlled Trials
Laparoscopy
Analgesics
Pain
Postoperative Pain
Opioid Analgesics
Postoperative Nausea and Vomiting
Cyclooxygenase 2 Inhibitors
Incidence
Dizziness
Visual Analog Scale
Morphine
Nausea
Vomiting
Anesthesia
Placebos
Databases
parecoxib

Keywords

  • COX-2 inhibitor
  • laparoscopic cholecystectomy
  • meta-analysis
  • pain relief
  • parecoxib

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Pain Relief by Parecoxib for Laparoscopic Cholecystectomy : A Meta-Analysis of Randomized Controlled Trials. / Lin, Yu Cih; Chen, Chien Yu; Liao, Yuan Mei; Lin, Pi Chu; Chang, Chuen Chau.

In: Asian Journal of Anesthesiology, Vol. 56, No. 3, 01.09.2018, p. 92-114.

Research output: Contribution to journalArticle

@article{8229d5b403834503a3c1444fe1ffce77,
title = "Pain Relief by Parecoxib for Laparoscopic Cholecystectomy: A Meta-Analysis of Randomized Controlled Trials",
abstract = "OBJECTIVE: The aim of this meta-analysis is to verify the effectiveness of postoperative pain relief by perioperative parecoxib, a selective intravenous cyclooxygenase-2 (COX-2) inhibitor, for patients receiving laparoscopic cholecystectomy (LC) surgery. METHODS: Electronic databases were searched for the randomized controlled trials (RCTs) to evaluate the effectiveness of pain relief by parecoxib or placebo for patients receiving LC surgery. The primary outcomes was the pain score evaluation using visual analogue scale (VAS). The secondary outcomes were the opioids consumption or analgesic supplement requirement and incidence of any adverse events such as dizziness, nausea and vomiting. RESULTS: Ten trials with 916 patients were included. Perioperative parecoxib significantly reduced postoperative pain score with rest at post-anaesthesia care unit (PACU; mean difference [MD] = -0.58, 95{\%} confi dence interval [CI] = -1.04 to -0.12, p = 0.01) after LC. Postoperative opioid requirement or analgesic supplement for rescue of pain was also effectively reduced (relative risk [RR] = 0.47, 95{\%} CI = 0.33 to 0.66, p < 0.0001). The incidence of side effects such as postoperative nausea and vomiting (PONV) was unaffected (RR = 0.83, 95{\%} CI = 0.63 to 1.10, p = 0.20). CONCLUSION: Perioperative intravenous parecoxib could effectively provide pain relief and reduced postoperative morphine consumption or rescue analgesics for LC surgery without causing additional adverse concerns.",
keywords = "COX-2 inhibitor, laparoscopic cholecystectomy, meta-analysis, pain relief, parecoxib",
author = "Lin, {Yu Cih} and Chen, {Chien Yu} and Liao, {Yuan Mei} and Lin, {Pi Chu} and Chang, {Chuen Chau}",
year = "2018",
month = "9",
day = "1",
doi = "10.6859/aja.201803_56(3).0004",
language = "English",
volume = "56",
pages = "92--114",
journal = "Asian Journal of Anesthesiology",
issn = "2468-824X",
publisher = "Elsevier Taiwan LLC",
number = "3",

}

TY - JOUR

T1 - Pain Relief by Parecoxib for Laparoscopic Cholecystectomy

T2 - A Meta-Analysis of Randomized Controlled Trials

AU - Lin, Yu Cih

AU - Chen, Chien Yu

AU - Liao, Yuan Mei

AU - Lin, Pi Chu

AU - Chang, Chuen Chau

PY - 2018/9/1

Y1 - 2018/9/1

N2 - OBJECTIVE: The aim of this meta-analysis is to verify the effectiveness of postoperative pain relief by perioperative parecoxib, a selective intravenous cyclooxygenase-2 (COX-2) inhibitor, for patients receiving laparoscopic cholecystectomy (LC) surgery. METHODS: Electronic databases were searched for the randomized controlled trials (RCTs) to evaluate the effectiveness of pain relief by parecoxib or placebo for patients receiving LC surgery. The primary outcomes was the pain score evaluation using visual analogue scale (VAS). The secondary outcomes were the opioids consumption or analgesic supplement requirement and incidence of any adverse events such as dizziness, nausea and vomiting. RESULTS: Ten trials with 916 patients were included. Perioperative parecoxib significantly reduced postoperative pain score with rest at post-anaesthesia care unit (PACU; mean difference [MD] = -0.58, 95% confi dence interval [CI] = -1.04 to -0.12, p = 0.01) after LC. Postoperative opioid requirement or analgesic supplement for rescue of pain was also effectively reduced (relative risk [RR] = 0.47, 95% CI = 0.33 to 0.66, p < 0.0001). The incidence of side effects such as postoperative nausea and vomiting (PONV) was unaffected (RR = 0.83, 95% CI = 0.63 to 1.10, p = 0.20). CONCLUSION: Perioperative intravenous parecoxib could effectively provide pain relief and reduced postoperative morphine consumption or rescue analgesics for LC surgery without causing additional adverse concerns.

AB - OBJECTIVE: The aim of this meta-analysis is to verify the effectiveness of postoperative pain relief by perioperative parecoxib, a selective intravenous cyclooxygenase-2 (COX-2) inhibitor, for patients receiving laparoscopic cholecystectomy (LC) surgery. METHODS: Electronic databases were searched for the randomized controlled trials (RCTs) to evaluate the effectiveness of pain relief by parecoxib or placebo for patients receiving LC surgery. The primary outcomes was the pain score evaluation using visual analogue scale (VAS). The secondary outcomes were the opioids consumption or analgesic supplement requirement and incidence of any adverse events such as dizziness, nausea and vomiting. RESULTS: Ten trials with 916 patients were included. Perioperative parecoxib significantly reduced postoperative pain score with rest at post-anaesthesia care unit (PACU; mean difference [MD] = -0.58, 95% confi dence interval [CI] = -1.04 to -0.12, p = 0.01) after LC. Postoperative opioid requirement or analgesic supplement for rescue of pain was also effectively reduced (relative risk [RR] = 0.47, 95% CI = 0.33 to 0.66, p < 0.0001). The incidence of side effects such as postoperative nausea and vomiting (PONV) was unaffected (RR = 0.83, 95% CI = 0.63 to 1.10, p = 0.20). CONCLUSION: Perioperative intravenous parecoxib could effectively provide pain relief and reduced postoperative morphine consumption or rescue analgesics for LC surgery without causing additional adverse concerns.

KW - COX-2 inhibitor

KW - laparoscopic cholecystectomy

KW - meta-analysis

KW - pain relief

KW - parecoxib

UR - http://www.scopus.com/inward/record.url?scp=85058921837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058921837&partnerID=8YFLogxK

U2 - 10.6859/aja.201803_56(3).0004

DO - 10.6859/aja.201803_56(3).0004

M3 - Article

C2 - 30583331

AN - SCOPUS:85058921837

VL - 56

SP - 92

EP - 114

JO - Asian Journal of Anesthesiology

JF - Asian Journal of Anesthesiology

SN - 2468-824X

IS - 3

ER -